ArticleVeterinary medicine and science2025
Evaluation of Direct Economic Losses Due to Foot and Mouth Disease Reported by the Epidemiological Surveillance System in Cameroon From 2009 to 2023.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endemic Circulation and Genetic Characterization of Foot-and-Mouth Disease Virus in Buffalo Populations of Bangladesh.Transboundary and emerging diseases · 2026Article
- Evaluation of Direct Economic Losses Due to Foot and Mouth Disease Reported by the Epidemiological Surveillance System in Cameroon From 2009 to 2023.Veterinary medicine and science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot and mouth disease (FMD), a highly contagious viral disease, is prevalent in Cameroon. Outbreaks are often observed, and the livestock industry is at serious risk of production loss. This study aimed to estimate the economic costs of FMD from 2009 to 2023. The economic impact of FMD is determined by evaluating immediate, evident production losses, such as mortality losses, decreases in milk production, and veterinary costs, which are usually faced by farmers. The expected total direct economic losses were USD 898170.228, with a standard deviation of USD 145000.078. The average economic loss per outbreak was USD 3302.096. The estimated average monetary value of mortality-related losses for an adult is USD 482.713, and for a calf, it is USD 112.255. Lower milk production resulted in losses ranging from USD 71.686 to USD 134.630 per cow. Finally, it was estimated that the cost of treating secondary infections in each sick cow would be USD 8.393. These economic losses, which also represent a sizable financial loss for persons employed in the sector, result in taxes and financial losses for the State.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.